Percutaneous cryoablation and 125I seed implantation combined with chemotherapy for advanced pancreatic cancer: Report of 67 cases

Chinese Journal of Oncology

Volumn 34, Issue 12, 2012, Pages 940-944

  Niu, Li Zhi ^a   He, Li Hua ^a   Zhou, Liang ^a   Yang, Zhen Zhong ^a   Zuo, Jian Sheng ^a   Xu, Ke Cheng ^a  

^a Fuda Cancer Hospital of Guangzhou   (China)

Author keywords

125I; Cryosurgery; Pancreatic neoplasms; Treatment outcome

Indexed keywords

GEMCITABINE; IODINE 123; ANTINEOPLASTIC AGENT; CISPLATIN; DEOXYCYTIDINE; DRUG DERIVATIVE; RADIOACTIVE IODINE;

ABDOMINAL BLEEDING; ACUTE PANCREATITIS; ADVANCED CANCER; ARTICLE; BILE LEAKAGE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CRYOABLATION; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PANCREAS CANCER; PANCREAS FISTULA; PATIENT SAFETY; PROGRESSION FREE SURVIVAL; SCORING SYSTEM; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT GAIN; ADULT; AGED; BRACHYTHERAPY; CRYOSURGERY; DISEASE FREE SURVIVAL; FEMALE; LIVER TUMOR; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PANCREAS TUMOR; PATHOLOGY; SURVIVAL RATE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CISPLATIN; COMBINED MODALITY THERAPY; CRYOSURGERY; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

MLCS; MLOWN;

EID: 84881282290     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3766.2012.12.013     Document Type: Article

References (17)

1. Cooperman AM. Pancreatic cancer: the bigger picture. Surg Clin North Am, 2001, 81 :557-574.
2. Eisenhauer KA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer, 2009, 45:228-247.
3. Burris HA 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol, 1997, 15,2403-2413.
4. Colueci G, Lahianca R, Di Costanzo F, et al. Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer, the GIP-1 study. J Clin Oncol, 2010, 28; 1645-1651.
5. Joosten JJ, Muijen GN, Wohbes T, et al. In vivo destruction of tumor tissue by cryoablation can induce inhibition of secondary tumor growth: an experimental study. Cryobiology, 2001, 42;49- 58.
6. Sabel MS. Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses. Cryobiology, 2009, 58:1 -11.
7. Chiu D, Niu I., Mu F, et al. The experimental study for efficacy and safety of pancreatic: cryosurgery. Cryobiology, 2010, 60; 281- 286.
8. Korpan NN. Cryosurgery: ultrastructural changes in pancreas tissue after low temperature exposure. Technol Cancer Res Treat, 2007, 6:59-67.
9. Petrone MC, Arcidiacono PC, Carrara S, et al. US-guided application of a new hybrid probe in human pancreatic adenocarcinoma: an ex vivo study. Castrointest Endosc, 2010, 71, 1294-1297.
10. Popken F, Serfert JK, Engelmann R, et al. Comparison of iceball diameter and temperature distribution achieved with 3-mm accuprobe cryoprobes in porcine and human liver tissue and human colorectal liver metastases in vitro. Cryobiology, 2000, 40,302- 310.
11. Mala T, Samset F, Aurdal L, et al. Magnetic resonance imuging- estimated three-dimensional temperature distribution in liver cryolesions: a study of cryolesion characteristics assumed necessary for tumor ablation. Cryobiogy, 2001, 43, 268-275.
12. Seifert JK, Gerhara CD, Mattes F, et al. A pig model of hepatic cryotherapy. In vivo temperature distribution during freezing and histopathological changes. Cryobiology, 2003, 47,214-226.
13. Kindler HL., Friberg G, Singh DA, et al. Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer. Clin Oncol, 2005, 23,8033-8040.
14. Ardavanis A, Kountourakis P, Karagiannis A, et al. Biweekly gemcitabine ((JEM) in combination with erlotinib (ERI.): an active and convenient regimen for advanced pancreatic cancer. Anticancer Res, 2009, 29: 5211-5217.
15. Sudo K, Yamaguchi T, Nakamura K, et al. Phase II study of S- 1 in patients with gemcitabine-resistant advanced pancreatic cancer. Cancer Chemother Pharmacol, 2011, 67 :249-254.
16. Chen XL, Ma Y, Wan Y, et al. Experimental study of the safety of pancreas cryosurgery: the comparison of 2 different techniques of cryosurgery. Pancreas, 2010, 39:92-96.
17. Xu KC, Niu LZ, Hu YZ, et al. A pilot study on combination of cryosurgery and (125) iodine seed implantation for treatment of locally advanced pancreatic cancer. World J Gastroenterol, 2008, 14,1603-1611.